FI873701A - Menetelmä kylmäkuivattujen farmaseuttisten fenyylikinoliinikarboksyylihappokoostumusten valmistamiseksi - Google Patents

Menetelmä kylmäkuivattujen farmaseuttisten fenyylikinoliinikarboksyylihappokoostumusten valmistamiseksi Download PDF

Info

Publication number
FI873701A
FI873701A FI873701A FI873701A FI873701A FI 873701 A FI873701 A FI 873701A FI 873701 A FI873701 A FI 873701A FI 873701 A FI873701 A FI 873701A FI 873701 A FI873701 A FI 873701A
Authority
FI
Finland
Prior art keywords
preparation
carboxylic acid
lyophilized pharmaceutical
acid preparations
phenylquinoline
Prior art date
Application number
FI873701A
Other languages
English (en)
Swedish (sv)
Other versions
FI873701A0 (fi
FI90824C (fi
FI90824B (fi
Inventor
Chien-Chin Wu
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of FI873701A0 publication Critical patent/FI873701A0/fi
Publication of FI873701A publication Critical patent/FI873701A/fi
Application granted granted Critical
Publication of FI90824B publication Critical patent/FI90824B/fi
Publication of FI90824C publication Critical patent/FI90824C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI873701A 1986-08-28 1987-08-26 Menetelmä kylmäkuivattujen farmaseuttisten fenyylikinoliinikarboksyylihappokoostumusten valmistamiseksi FI90824C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US90125486A 1986-08-28 1986-08-28
US90125486 1986-08-28
US07/060,203 US4889862A (en) 1986-08-28 1987-06-10 Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids
US6020387 1987-06-10

Publications (4)

Publication Number Publication Date
FI873701A0 FI873701A0 (fi) 1987-08-26
FI873701A true FI873701A (fi) 1988-02-29
FI90824B FI90824B (fi) 1993-12-31
FI90824C FI90824C (fi) 1994-04-11

Family

ID=26739681

Family Applications (1)

Application Number Title Priority Date Filing Date
FI873701A FI90824C (fi) 1986-08-28 1987-08-26 Menetelmä kylmäkuivattujen farmaseuttisten fenyylikinoliinikarboksyylihappokoostumusten valmistamiseksi

Country Status (17)

Country Link
US (1) US4889862A (fi)
EP (1) EP0261426B1 (fi)
JP (1) JP2629005B2 (fi)
KR (1) KR950006218B1 (fi)
AU (1) AU602715B2 (fi)
CA (1) CA1312824C (fi)
DE (1) DE3782480T2 (fi)
DK (1) DK168655B1 (fi)
ES (1) ES2052530T3 (fi)
FI (1) FI90824C (fi)
GR (1) GR3006608T3 (fi)
HU (1) HU199289B (fi)
IE (1) IE60490B1 (fi)
IL (1) IL83662A (fi)
NO (1) NO873626L (fi)
NZ (1) NZ221574A (fi)
PT (1) PT85612B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861783A (en) * 1988-04-26 1989-08-29 E. I. Du Pont De Nemours And Company 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases
HU206975B (en) * 1991-03-14 1993-03-01 Reanal Finomvegyszergyar Process for producing granulation and veterinary composition comprising water-soluble flumequine complex
US6417167B1 (en) 1997-02-05 2002-07-09 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing shingoglycolipid and process for preparing them
CA2280130C (en) * 1997-02-05 2007-12-18 Kirin Beer Kabushiki Kaisha Lyophilized compositions containing sphingoglycolipid and process for preparing them
TWI232102B (en) * 2001-07-17 2005-05-11 Shionogi & Co A pharmaceutical formulation for injection
US20060008529A1 (en) * 2004-07-12 2006-01-12 Meyerhoff Mark E Use of additive sites to control nitric oxide release from nitric oxide donors contained within polymers
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
WO2007064895A2 (en) * 2005-12-02 2007-06-07 The Regents Of The University Of Michigan Polymer compositions, coatings and devices, and methods of making and using the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US468299A (en) * 1892-02-02 John atkinson
DE433646C (de) * 1923-09-15 1926-09-09 Chem Fab Vorm E Schering Verfahren zur Herstellung in Wasser leicht loeslicher Derivate von Carbonsaeuren derChinolin- und Pyridinreihe
US3681495A (en) * 1969-08-25 1972-08-01 American Home Prod Freeze dried echothiophate iodide compositions
JPS5071816A (fi) * 1973-11-02 1975-06-14
US4036954A (en) * 1973-11-02 1977-07-19 Yamanouchi Pharmaceutical Co., Ltd. Stable prostaglandin E group-containing formulation
AT356278B (de) * 1976-07-12 1980-04-25 Hoffmann La Roche Verfahren zur herstellung von injektions- loesungen
JPS5976017A (ja) * 1983-01-20 1984-04-28 Yamanouchi Pharmaceut Co Ltd 安定なプロスタグランジンｅ類製剤の製法
CA1288436C (en) * 1983-07-22 1991-09-03 David Paul Hesson Phenylquinolinecarboxylic acids and derivatives as antitumor agents
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
DE3329952A1 (de) * 1983-08-19 1985-02-28 Behringwerke Ag, 3550 Marburg Verfahren zur verringerung einer truebung in kontrollseren
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs

Also Published As

Publication number Publication date
NO873626L (no) 1988-02-29
EP0261426B1 (en) 1992-11-04
HUT45398A (en) 1988-07-28
FI873701A0 (fi) 1987-08-26
ES2052530T3 (es) 1994-07-16
IL83662A0 (en) 1988-01-31
US4889862A (en) 1989-12-26
DK447887A (da) 1988-02-29
KR950006218B1 (ko) 1995-06-12
NZ221574A (en) 1989-11-28
DK447887D0 (da) 1987-08-27
FI90824C (fi) 1994-04-11
GR3006608T3 (fi) 1993-06-30
NO873626D0 (no) 1987-08-27
HU199289B (en) 1990-02-28
IE872290L (en) 1988-02-28
AU7762287A (en) 1988-03-03
IE60490B1 (en) 1994-07-27
EP0261426A1 (en) 1988-03-30
PT85612A (en) 1987-09-01
FI90824B (fi) 1993-12-31
KR880002507A (ko) 1988-05-09
IL83662A (en) 1991-09-16
JPS63115816A (ja) 1988-05-20
PT85612B (pt) 1990-05-31
DK168655B1 (da) 1994-05-16
CA1312824C (en) 1993-01-19
AU602715B2 (en) 1990-10-25
DE3782480T2 (de) 1993-04-08
JP2629005B2 (ja) 1997-07-09
DE3782480D1 (de) 1992-12-10

Similar Documents

Publication Publication Date Title
FI892881A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminohappojohdannaisten va lmistamiseksi
NO862734D0 (no) Fremgangsmaate for fremstilling av hyaluronsyreestere.
FI873205A0 (fi) Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
FI860484A (fi) Menetelmä terapeuttisesti aktiivisten peptidijohdannaisten valmistamiseksi
FI893520A0 (fi) Menetelmä intravenoosisen farmaseuttisen koostumuksen valmistamiseksi
FI875235A (fi) Menetelmä valmistaa terapeuttisesti aktiivisia tetrahydro(imidatsolyylimetyyli)-4H-karbatsol-4-oneja
FI98830B (fi) Menetelmä bifunktionaalisten proteiinien valmistamiseksi
NO179359C (no) Fremgangsmåte for fremstilling av farmasöytisk preparat inneholdende somatostatinanaloger.
FI882669A0 (fi) Menetelmä farmaseuttisesti aktiivisten alfa-halogenoitujen dikarboksyylihappojen valmistamiseksi
NO872551D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
FI881303A0 (fi) Menetelmä ibuprofeenin valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI872769A (fi) Menetelmä alfa-mono-olefiinien polymeroimiseksi
FI873701A0 (fi) Menetelmä kylmäkuivattujen farmaseuttisten fenyylikinoliinikarboksyylihappokoostumusten valmistamiseksi
FI92065C (fi) Menetelmä farmaseuttisten piperidiinijohdannaisten valmistamiseksi
FI890723A0 (fi) Menetelmä kinoliinikarboksyylihappojohdannaisten valmistamiseksi
NO874200D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
FI94351B (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidijohdannaisten valmistamiseksi
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
NO174085C (no) Fremgangsmåte for fremstilling av sukralfatpreparater
NO873423D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO872233D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO875359L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
FI901550A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten di-imidatsopyrimidiini- ja imidatsopyratsolopyrimidiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
FG Patent granted

Owner name: HAAB, KARL

BB Publication of examined application
BB Publication of examined application
MM Patent lapsed

Owner name: THE DU PONT MERCK PHARMACEUTICAL COMPANY